Markets
English
 

Trade Inovio Pharmaceuticals, Inc. - INO CFD

1m
5m
15m
30m
1H
4H
1D
1W

Trader sentiment

% Buyers % Sellers
  • Long position overnight fee -0.0225%
    Margin $1,000.00
    Overnight feeCharges from borrowed part ($-0.90) -0.0225 %
  • Short position overnight fee -0.0219%
    Margin $1,000.00
    Overnight feeCharges from borrowed part ($-0.88) -0.0219 %
  • Overnight fee time 22:00 (UTC)
  • Min traded quantity 1
  • Currency USD
  • Margin 20%
  • Stock exchange United States of America
  • Trading hours (UTC)
    Mon: 09:10 - 00:00
    Tue - Thu: 00:00 - 01:00
    09:10 - 00:00
    Fri: 00:00 - 01:00
    09:10 - 22:00
  • Commission on trade 0%

0+

Traders

0+

Active clients monthly

$0+

Monthly investing volume

$0+

Withdrawn each month

Inovio Pharmaceuticals, Inc., a late-stage biotechnology company, focuses on the discovery, development, and commercialization of DNA-based immunotherapies and vaccines to prevent and treat cancers and infectious diseases. Its SynCon immunotherapy design has the ability to break the immune system''s tolerance of cancerous cells, as well as is intended to facilitate cross-strain protection against known, as well as new unmatched strains of pathogens, such as influenza. The company is involved in conducting and planning clinical studies of its proprietary SynCon immunotherapies for human papillomavirus-caused pre-cancers and cancers; glioblastoma multiforme; hepatitis B virus; hepatitis C virus; human immunodeficiency virus; Ebola virus; middle east respiratory syndrome; and Zika virus. Its partners and collaborators include The Wistar Institute; University of Pennsylvania; GeneOne Life Science Inc.; ApolloBio Corporation; Regeneron Pharmaceuticals, Inc.; Genentech, Inc.; Plumbline Life Sciences, Inc.; Drexel University; National Institute of Allergy and Infectious Diseases; United States Military HIV Research Program; U.S. Army Medical Research Institute of Infectious Diseases; National Institutes of Health; HIV Vaccines Trial Network; Defense Advanced Research Projects Agency; the Parker Institute for Cancer Immunotherapy; QIAGEN N.V.; Coalition for Epidemic Preparedness Innovations; and Beijing Advaccine Biotechnology Co. Inovio Pharmaceuticals, Inc. was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

Inovio Pharmaceuticals, Inc. Stock Sinks As Market Gains: What You Should Know

It might be of some concern to shareholders to see the Inovio Pharmaceuticals, Inc. (INO) share price down -1.06% in the last day.

14:56, 28 January 2022 Learn more about

Trade shares with leverage

Shares are available to trade with up to 5:1 leverage. Start trading with as little as $100 to control a position of $500

Shares CFDs

  • Trade 24/5 on a wide range of shares

  • Trading opportunities in both a rising and falling market

Profit and loss control

You can easily define Stops and Limits to request positions to close at a specified price.

Set up price alerts to be informed of big moves.

You might be interested in

Still looking for a broker you can trust?


Join the 300,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account

2. Make your first deposit

3. You’re all set. Start trading